October 4, 2016 William K. McVicar, Ph.D.Inotek Pharmaceuticals Corp • November 9th, 2016 • Pharmaceutical preparations • Massachusetts
This letter confirms that you will be transitioning from your role as Executive Vice President, Chief Scientific Officer at Inotek Pharmaceuticals Corporation (“Inotek” or the “Company”). On behalf of the Company and its Board of Directors (the “Board”), please accept our sincere appreciation for your years of service and contributions to the Company. With that in mind, this letter proposes an agreement setting forth the terms of your transition (the “Agreement”).
